Loading clinical trials...

A Prospective Cohort Study of IgG4RD in China | Clinical Trials | Clareo Health

Back to clinical trial search

RECRUITINGNCT01670695

A Prospective Cohort Study of IgG4RD in China

This is an cohort study to investigate the disease course and treatment response of patients with IgG4-related disease.

Lead sponsor: Peking Union Medical College Hospital•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Hua Chen, MD

CONTACT

86-10-69158797 [email protected]

Related studies

RECRUITINGPhase 2

A Study of Efgartigimod in Patients With IgG4-Related Disease

NCT07025330 · IgG4-related Disease

RECRUITINGPhase 1

A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases

NCT06978647 · Systemic Lupus Erythematosus (SLE), Systemic Sclerosis (SSc), and more

RECRUITINGNA

Short-term Glucocorticoid Combined with MMF for IgG4-RD

NCT06663618 · IgG4-related Disease

RECRUITINGEARLY Phase 1

Safety and Efficacy of PRG-2311 for Refractory Lupus Nephritis and IgG4-Related Disease

NCT06497361 · Lupus Nephritis, IgG4-related Disease

RECRUITINGPhase 2

Drug Rediscovery for Rare Immune Mediated Inflammatory Diseases

NCT06285539 · Behcet's Disease, Idiopathic Inflammatory Myopathies, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 11, 2017Terms

Trial snapshot

StatusRECRUITING

Phase—

Enrollment1,000

Start dateJan 2012

Last updatedApr 11, 2017

Condition

IgG4-related Disease

Locations shown

Deptment of Rheumatology, Peking Union Medical College Hospital

Beijing, Beijing Municipality

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 11, 2017Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions